Skip to content
Recall Observatory FDA recall evidence

Drug product

Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64

D-0509-2024

May 20, 2024

Class II

Product summary

Firm
Genentech, Inc.
Event
Event 94653
Status
Terminated
Classification
Class II
Quantity
Lot:3618858 = 105,759; Lot:3618873 =90,359
Official record key
drug-enforcement:D-0509-2024

Official wording

Reason: Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Code information: Lot #: 3618858, 3618873, Exp. Date 01/31/2026

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility